Journal info | Norwegian Register

Bibliographic Information

International Title:

Frontiers in Immunology

e-ISSN:

1664-3224 Period: [2010 .. ]

Language:

English

Country of publication:

Switzerland

URL:

https://www.frontiersin.org/journals/immunology

Publishing House:

Frontiers Media S.A.

ITAR Code:

1022379

This field is being removed. Please contact us if you have questions.

NPI Scientific Field:

Biomedicine

Open Access

Included in publishing agreement :

Consortium agreement Publishing agreement includes articles with author associated with one of the institutions. We collect data from openscience.no datasource, which in periods deviate from website openscience.no. Read more on openscience.no for details about this agreement.

Publishing agreement includes articles with author associated with one of the institutions. We collect data from openscience.no datasource, which in periods deviate from website openscience.no. Read more on openscience.no for details about this agreement.

Valid until December 31 2024

Frontiers

42 Institutions in Agreement: Show [+]

Akershus universitetssykehus HF
Direktoratet for strålevern og atomsikkerhet
Folkehelseinstituttet
Forskningsstiftelsen Fafo
Handelshøyskolen BI
Havforskningsinstituttet
Høgskolen i Innlandet
Høgskolen i Østfold
Høgskulen på Vestlandet
Høyskolen Kristiania
Institutt for samfunnsforskning
Nasjonalt kunnskapssenter om vold og traumatisk stress
NILU - Norsk institutt for luftforskning
Nofima
NORCE Norwegian Research Centre AS
Nord Universitet
Norges Geotekniske Institutt
Norges Idrettshøgskole
Norges teknisk-naturvitenskapelige universitet
Norsk institutt for bioøkonomi
Norsk institutt for naturforskning
Norsk institutt for vannforskning
Norsk Utenrikspolitisk Institutt
NUBU – Nasjonalt utviklingssenter for barn og unge
OsloMet - Storbyuniversitetet
SINTEF AS
SINTEF Energi AS
SINTEF Manufacturing
SINTEF Narvik
SINTEF Ocean
Sykehuset Østfold HF
Sørlandet sykehus HF
Transportøkonomisk institutt
UiT Norges arktiske universitet
Universitetet i Agder
Universitetet i Bergen
Universitetet i Oslo
Universitetet i Stavanger
Universitetet i Sørøst-Norge
Universitetssenteret på Svalbard
Vestre Viken HF
Veterinærinstituttet

Read more about this publishing agreement on openscience.no

Plan S: Journal Checker Tool [+] When e-ISSN is not matched then try manually copy & paste p-ISSN to test that too

Scientific level placements and Norwegian HEIs publication points

Year	Scientific Level	Author Shares	Publication Points
2024	1
2023	1
2022	1	14.9977	36.0932
2021	1	31.001	56.9527
2020	1	13.6983	24.315
2019	1	15.5501	26.142
2018	1	9.4077	16.6956
2017	1	7.5269	13.5239
2016	1	6.2111	9.9917
2015	1	7.8327	10.4155
2014	1	3.6287	3.6287
2013	1	2.85	2.85
2012	1	1.3	1.3
Published in May the following year

Year

Scientific Level

Author Shares

Publication Points

2024

2023

2022

14.9977

36.0932

2021

31.001

56.9527

2020

13.6983

24.315

2019

15.5501

26.142

2018

9.4077

16.6956

2017

7.5269

13.5239

2016

6.2111

9.9917

2015

7.8327

10.4155

2014

3.6287

2013

2.85

2012

1.3

Published in May the following year

Comments

Comments regarding updates on the publication channel are only visible for you and the advisors. Comments regarding the scientific quality and levels will be public.

Brukes noe av norske forfattere. Inneholder mye review artikler. Av denne grunn beholdes den i kategori 1. I kategori 1 i Finnland.

On basis of the previous arguments, I would like to propose FI for upgrade and inclusion into the Scientific Level 2.

Frontiers in Immunology (FI) is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational, and clinical immunology. Field Chief Editor Luigi Daniele Notarangelo is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians, and the public worldwide. Impact Factor 7.561, Q1, Cite score 8.1. Besides, according to the JCR, FI is the 5th most cited immunology journal in the world. FI is the official journal of the International Union of Immunological Societies (IUIS). Encompassing the entire field of Immunology, this journal welcomes papers that investigate basic mechanisms of immune system development and function, with a particular emphasis given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis. Further, the availability of a growing number of biological drugs, coupled with a fine characterization of the molecular mechanisms of disease, has now made precision medicine a desirable approach for many immunological disorders. FI portrays how advances in scientific knowledge and technology may translate into novel approaches to diagnosis and treat immune disorders, both in animal and cellular models and in humans. All manuscripts submitted to FI that reports on studies conducted on human subjects must conform with current regulation and the Declaration of Helsinki and must receive approval from the Institutional Review Board and patient informed consent. Animal welfare and Ethics Committee approvals are required for studies involving animals. FI is a member of the Committee on Publication Ethics.